Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas

NCT06381570 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Low-grade Glioma

Interventions

DRUG: Tovorafenib
DRUG: Vinblastine

Sponsor

Daniel Morgenstern

Collaborators

[object Object]